dobutamine has been researched along with du-21220 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dunn, WJ; Wold, S | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Brikas, P; Buéno, L; Fioramonti, J | 2 |
Berlin, I; Danjou, P; Guillemant, S; Puech, AJ; Touitou, Y | 1 |
1 trial(s) available for dobutamine and du-21220
Article | Year |
---|---|
Beta-adrenoceptor agonists do not stimulate daytime melatonin secretion in healthy subjects. A double blind placebo controlled study.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Cross-Over Studies; Dobutamine; Double-Blind Method; Female; Humans; Male; Melatonin; Ritodrine | 1995 |
5 other study(ies) available for dobutamine and du-21220
Article | Year |
---|---|
Structure-activity study of beta-adrenergic agents using the SIMCA method of pattern recognition.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anura; In Vitro Techniques; Models, Biological; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1978 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Central and peripheral beta-adrenergic control of gastrointestinal motility in sheep.
Topics: Animals; Dobutamine; Gastrointestinal Motility; Intestine, Small; Ritodrine; Sheep; Stomach, Ruminant | 1990 |
Central and peripheral beta-adrenergic influences on reticulo-rumen and upper-gut myoelectrical activity in sheep.
Topics: Acebutolol; Animals; Dobutamine; Duodenum; Electromyography; Female; Gastrointestinal Motility; Intestine, Small; Isoproterenol; Jejunum; Propranolol; Receptors, Adrenergic, beta; Reticulum; Ritodrine; Rumen; Sheep | 1989 |